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Epicardial ablation has been adopted during the last 
years, mainly as a supplementary technique after a failed 
endocardial ablation procedure, both in patients with 
ischemic and nonischemic ventricular tachycardias (VTs). 
Sosa and colleagues were the first who described the 
percutaneous subxiphoidal puncture to approach the 
epicardial space in 1996.1 Using the 3D electroanatomic 
mapping systems, the endocardial and epicardial substrate 
mapping have become feasible during the same 
procedure. Because of its complexity and its potential 
risks this process is performed only in high experienced 
centers by skilled operators with a large number of VT 
ablation procedures.  
Endocardial ablation in patients with left ventricular 
nonischemic cardiomyopathy (NICM) has shown worst 
outcome compared with ablation in ischemic 
cardiomyopathy. The main reason seems to be the 
progressive nature of the disease and the presence of 
epicardial and intramural slow conduction areas forming 
reentry circuits. The pattern of fibrosis and scar in NICM 
is not predictable as in ischemic cardiomyopathy where it 
follows the distribution of the coronary artery disease. 
Data from the study of Hsia et al2 in patients with NICM 
and VT episodes supported that the critical endocardial 
low voltage substrate was located mainly in the basal and 
perivalvular area. In this study, epicardial mapping was 
performed only in few patients revealing abnormal 
fragmented potentials but data from later studies 
highlighted the important of epicardial substrate in 
NICM.2 Cano et al3 performed both endocardial and 
epicardial mapping in 22 patients either because of failed 
endocardial ablation or because of electrocardiographic 
signs suggesting epicardial localization of the exit point. 
Electroanatomic mapping revealed extended epicardial 
low voltage areas in the majority of the patients (about 
82%) which were located mostly in basal left ventricular 
lateral wall. However, Haqqani et al4 described 31 of 266 
patients with NICM (11.6%) who had septal involvement, 
mainly in the basal region, without lateral low voltage 
areas.  
 
Identification of epicardial substrate 
Electrocardiographic criteria identifying VT epicardial 
origin 
During the last years several electrocardiographic 
criteria have been proposed for the diagnosis of an 
epicardial VT. The most important study was published 
from Berruezo et al 6 suggesting the following criteria for 
left ventricular epicardial origin: pseudodelta wave ≥34 
milliseconds, intrinsicoid deflection in V2 ≥85 
milliseconds and an R/S complex duration ≥121 
milliseconds. These parameters were derived after 
epicardial pacing mainly in postinfarction patients and 
their specificity and sensitivity was found that was 
affected from the left ventricular paced region. A later 
published paper suggested that from these parameters 
only the intrinsicoid deflection ≥85 milliseconds was 
consistent with the diagnosis of epicardial VT in patients 
with NICM.6 A specific algorithm for the NICM 
epicardial VTs was published in 2010 by Valles and 
colleagues7 suggesting as diagnostic criteria the absence 
of a q wave in the inferior leads, a pseudo delta wave ≥75 
milliseconds, a maximum deflection index (defined as the 
time from the beginning of the QRS to the earliest 
maximal deflection in any of the precordial leads divided 
by the maximal QRS duration >0.59 and the presence of a 
q wave in lead I (Figure 1). Moreover, recently was 
reported that even during sinus rhythm the presence of R 
wave ≥0.15 mV in V1, S wave ≥ 0.15 mV in V6 and/or a 
S/R ratio >0.20 mV in V6  reveal epicardial origin of VT 
in patients with NICM.8  
 
Figure 1. Four-step algorithm for the identification of an 
epicardial VT in NICM as proposed by Valles et al7. 






In patients with structural heart disease remarkable 
bipolar voltage attenuation is usually recorder in areas 
characterized as fibrotic or scar. Patients with NICM 
presenting with VT commonly have fragmented 
endocardial electrograms (EGMs) and late potentials, 
suggesting reentry circuit areas with nonuniform and 
delayed electrical activation. Substrate mapping during 
VT ablation includes commonly the combination of 
voltage and pace mapping, especially in patients with 
well tolerated stable VTs. Bipolar EGMs amplitude lower 
than 1.5 mV is indicative of scar although the sensitivity 
of this cut-off threshold is not high.9 The role of unipolar 
endocardial recordings in the identification of epicardial 
scar in patients with NICM seems to be significant, as it 
has proved that a value ≤8.27 mV in endocardial surface 
predicts a corresponding epicardial scar.10 In patients with 
arrhythmogenic right ventricular cardiomyopathy/ 
dysplasia (ARVC/D), this cut-off value for unipolar 
EGMs for the assessment of epicardial involvement has 
been proposed to be <5.5 mV.11  
There are many barriers in the epicardial voltage 
mapping process and subsequent ablation coming mainly 
from the poor contact between the catheter tip and the 
tissue due to the possible existence of pericardial 
adhesions and/or epicardial fat. Furthermore, the 
epicardial scar is often found adjacent to the epicardial 
coronary arteries or left phrenic nerve which crosses 
along the left ventricular free wall, thus requiring 
particular attention to avoid potential complications. 
Magnetic resonance imaging (MRI) 
The first study that demonstrated a correlation 
between the extent of transmural scar and the 
arrhythmogenic risk in patients with NICM was 
published from Nazarian et al.13 Patients with 25-75% 
extent of scar in MRI predicted inducible VT in the 
electrophysiology study. Bogun et al14 demonstrated that 
the “delayed enhanced MR imaging” technique could 
partly identify the location of scar, endocardial or 
epicardial, in pre-ablation MRI to identify the potential 
successful ablation sites.  
Clinical outcomes 
The efficacy of ablation in patients with NICM has 
significantly improved with the introduction of epicardial 
ablation additionally to the endocardial approach. The 
incidence of the abnormal fragmented and low voltage 
epicardial and endocardial electrograms has been reported 
to be higher in patients with inducible VTs compared to 
those without inducible VTs.12 Sojema et al15 performed 
epicardial ablation in 29% of the total patients after the 
failure of the endocardial procedure and they found that 
in these patients the scar area war larger in the epicardium 
compared to endocardium. After a follow up of one year 
the survival free of VT was 54%. Similarly, the study of 
Cano et al3 showed greater epicardial scar in conjunction 
with wider and more fragmented EGMs. During a follow 
up of 18±7 months 78% of the patients who underwent 
epicardial ablation were free of arrhythmia suggesting 
high percentage of abnormal epicardial tissue. Schmidt et 
al16 performed epicardial ablation in 15 patients with 
NICM who had undergone a failed endocardial procedure 
and VT was not inducible in 75% of them. 
Combined endocardial and epicardial ablation 
provides better outcomes in patients with NICM and 
recurrent VT episodes and ICD shocks. The lateral basal 
free wall seems to be the most common area with low 
voltage and slow conduction properties, facilitating the 
reentry mechanism.  Performing these operations requires 
special attention and experience in order to eliminate the 
arrhythmogenic burden and to avoid possible 
complications.   
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A 57-year-old Caucasian female was referred to our 
clinic due to hypertension, flushing, and diarrhea. She 
had a medical history of hypertension and paroxysmal 
atrial fibrillation. On physical examination, the patient 
had a heart rate of 70 bpm and a respiratory rate of 12 
breaths/min. Her temperature was 37°C and her blood 
pressure was 120/80 mmHg. Cardiac examination 
revealed a left parasternal holosystolic murmur, and a 
palpable right ventricular heave. Lung auscultation was 
unremarkable. From the initial biochemical exam she had 
no specific abnormalities. The ECG showed sinus 
rhythm, negative T-waves in leads III, V1-5. The 
transthoracic echocardiography study revealed a left 
ventricle with normal size and normal systolic function 
and dilatation of the left atrium, whereas the right cardiac 
chambers were dilated with thickened, immobile leaflets 
of the tricuspid and pulmonic valve, leading to 
malcoaptation and severe tricuspid and pulmonic 
regurgitation (Fig. 1-5). The clinical and 
echocardiographic findings raised the suspicion of 
carcinoid heart disease. Abdominal computed 
tomography (CT) demonstrated hepatic metastases and 
the patient was treated with chemotherapy and with the 
somatostatin analog octreotide. 
 
  
Figure 1. Right ventricular inflow view in systole showing 
thickened, immobile and retracted anterior and septal leaflets of 
tricuspid valve.  
 
  
Figure 2. Apical four-chamber view: color Doppler 
demonstrates severe tricuspid valve regurgitation.  
 
  
Figure 3. Apical 4-chamber view in systole: opened and 
retracted tricuspid valve (left); mitral valve is closed (right) 
